Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mitchell, P. Erbitux diagnostic latest adjunct to cancer therapy. Nat Biotechnol 22, 363–364 (2004). https://doi.org/10.1038/nbt0404-363
Issue Date:
DOI: https://doi.org/10.1038/nbt0404-363
- Springer Nature America, Inc.
This article is cited by
-
Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10
British Journal of Cancer (2012)
-
Emerging patent issues in genomic diagnostics
Nature Biotechnology (2006)
-
Cautious welcome for FDA pharmacogenomics guidance
Nature Biotechnology (2005)